Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A.; Orthopaedics and Traumatology Sports Center (CETE), Department of Orthopaedics and Traumatology, Paulista School of Medicine (EPM), Federal University of São Paulo, São Paulo, Brazil.
Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A.
Arthroscopy. 2019 Feb;35(2):659-667. doi: 10.1016/j.arthro.2018.08.031.
To investigate the long-term survivorship rates and functional outcomes of meniscal allograft transplantation (MAT) in patients with minimum 10-year postoperative follow-up.
Two reviewers independently searched EMBASE, MEDLINE, and PubMed from database inception for literature related to MAT according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. Data are reported in a narrative summary fashion with descriptive statistics.
Eleven studies with a total of 658 patients and 688 MATs were included. Mean age of patients was 33.1 years (range 14-66), of whom 63% were male. Mean survivorship rates were 73.5% at 10-year and 60.3% at 15-year follow-up, with 2 studies reporting 19- and 24-year survivorship of 50% and 15.1%, respectively. Pre- and postoperative Lysholm scores ranged from 36 to 60.5 and 61 to 75, respectively. Pre- and postoperative Tegner scores ranged from 1 to 3 and 2.5 to 4.6, respectively. Postoperative Knee injury and Osteoarthritis Outcome Score subset scores were as follows: Pain: 61.6 to 76.3; Symptoms: 57.9 to 61.8; Function in Daily Living: 68.5 to 79.9; Sport and Recreation: 33.9 to 49.3; Quality of Life: 37.3 to 45.9. Postoperative International Knee Documentation Committee scores ranged from 46 to 77. Regarding surgical technique, 194 MAT bone-fixation technique (53.8%) and 165 MAT suture-only fixation techniques (46.2%) were reported. The most common type of allograft used was cryopreserved (54.5% of the allografts). The most frequent concomitant procedures performed with MAT were to address chondral (20.8% of the cases) and ligament injuries (12.4% of the cases), and realignment procedures (9.4% of the cases). The most common complications observed that were not directly related to concomitant procedures were meniscal allograft partial tears (11.1%), arthrofibrosis (3.6%), and infection (2.0%). Several criteria were used among studies to define failure of MAT, the most common parameters being removal of meniscal allograft (8/11 studies) and conversion to total knee arthroplasty (7/11 studies).
MAT can yield good long-term survivorship rates, with 73.5% and 60.3% of allografts remaining functional after 10 and 15 years, respectively. Functional outcomes 10 years after MAT were fair and improved compared with preoperative scores.
Level IV, systematic review of Level III and IV studies.
研究至少 10 年术后随访的半月板同种异体移植(MAT)患者的长期生存率和功能结果。
两名审查员根据系统评价和荟萃分析的首选报告项目(PRISMA)检查表,独立检索 EMBASE、MEDLINE 和 PubMed 中与 MAT 相关的文献。数据以叙述性摘要的形式报告,并进行描述性统计。
11 项研究共纳入 658 名患者和 688 例 MAT。患者的平均年龄为 33.1 岁(范围 14-66),其中 63%为男性。10 年和 15 年随访的平均生存率分别为 73.5%和 60.3%,有 2 项研究分别报告了 19 年和 24 年的生存率为 50%和 15.1%。术前和术后 Lysholm 评分分别为 36-60.5 和 61-75。术前和术后 Tegner 评分分别为 1-3 和 2.5-4.6。术后膝关节损伤和骨关节炎结局评分亚组评分如下:疼痛:61.6-76.3;症状:57.9-61.8;日常活动功能:68.5-79.9;运动和娱乐:33.9-49.3;生活质量:37.3-45.9。术后国际膝关节文献委员会评分范围为 46-77。关于手术技术,报告了 194 例 MAT 骨固定技术(53.8%)和 165 例 MAT 单纯缝合固定技术(46.2%)。最常使用的同种异体移植物类型是冷冻保存(54.5%的同种异体移植物)。与 MAT 一起进行的最常见的伴随手术是处理软骨(20.8%的病例)和韧带损伤(12.4%的病例)以及重新排列手术(9.4%的病例)。观察到的最常见的与伴随手术无关的并发症是半月板同种异体移植部分撕裂(11.1%)、关节纤维化(3.6%)和感染(2.0%)。多项研究中使用了不同的标准来定义 MAT 失败,最常见的参数是同种异体移植物的移除(8/11 项研究)和全膝关节置换术的转换(7/11 项研究)。
MAT 可以产生良好的长期生存率,10 年和 15 年后分别有 73.5%和 60.3%的移植物保持功能。MAT 后 10 年的功能结果优于术前评分,且有所改善。
IV 级,对 III 级和 IV 级研究的系统评价。